Caricamento...
Use of immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis
Immunosuppressive therapy (IST) is one therapy option for treatment of patients with lower-risk myelodysplastic syndromes (MDS). However, the use of several different immunosuppressive regimens, the lack of high-quality studies, and the absence of validated predictive biomarkers pose important chall...
Salvato in:
| Pubblicato in: | Haematologica |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Ferrata Storti Foundation
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6939518/ https://ncbi.nlm.nih.gov/pubmed/31004015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2019.219345 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|